Paper39596173
Plasma Glutaminyl-Peptide Cyclotransferase Mediates Glucosamine-Metabolism-Driven Protection Against Hypertension: A Mendelian Randomization Study.
Ge F and 8 others. Int J Mol Sci, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Plasma Glutaminyl-Peptide Cyclotransferase Mediates Glucosamine-Metabolism-Driven Protection Against Hypertension: A Mendelian Randomization Study. Papers, record 39596173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39596173
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Plasma Glutaminyl-Peptide Cyclotransferase Mediates Glucosamine-Metabolism-Driven Protection Against Hypertension: A Mendelian Randomization Study.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mendelian Randomization Analysis | Major topic |
| Hypertension | Major topic |
| Genome-Wide Association Study | Major topic |
| Glucosamine | Major topic |
| Quantitative Trait Loci | Major topic |
| Humans | |
| Polymorphism, Single Nucleotide | |
| Dietary Supplements | |
| Genetic Predisposition to Disease | |
| Aminoacyltransferases |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2021YFA0805100 | National Key R&D Program of China | PubMed | ||
| U21A20342 | National Natural Science Foundation of China | PubMed | ||
| 81930106 | National Natural Science Foundation of China | PubMed | ||
| 82170545 | National Natural Science Foundation of China | PubMed | ||
| 2022A1515011872 | National Natural Science Foundation of Guangdong | PubMed | ||
| 2019A1515011295 | National Natural Science Foundation of Guangdong | PubMed | ||
| N/A | High-level Health Team Foundation of Zhuhai (2018) | PubMed |
Source PubMed
References84
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36029480 | Glucosamine and lower mortality and cancer incidence: Selection bias in the observational studies. | Pharmacoepidemiol Drug Saf | 2022 | https://conductscience.org/library/papers/36029480 | PubMed |
| 2 | 27061298 | Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. | Genet Epidemiol | 2016 | https://conductscience.org/library/papers/27061298 | PubMed |
| 3 | 38632649 | Osteoarthritis and hypertension: observational and Mendelian randomization analyses. | Arthritis Res Ther | 2024 | https://conductscience.org/library/papers/38632649 | PubMed |
| 4 | 7134225 | Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal. | Pharmatherapeutica | 1982 | https://conductscience.org/library/papers/7134225 | PubMed |
| 5 | 18756654 | Glucosamine. | Am Fam Physician | 2008 | https://conductscience.org/library/papers/18756654 | PubMed |
| 6 | 18363538 | Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database. | Pharmacotherapy | 2008 | https://conductscience.org/library/papers/18363538 | PubMed |
| 7 | 29126136 | DrugBank 5.0: a major update to the DrugBank database for 2018. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29126136 | PubMed |
| 8 | 38807172 | Blood metabolites and chronic kidney disease: a Mendelian randomization study. | BMC Med Genomics | 2024 | https://conductscience.org/library/papers/38807172 | PubMed |
| 9 | 36635386 | Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. | Nat Genet | 2023 | https://conductscience.org/library/papers/36635386 | PubMed |
| 10 | 35284849 | Practical, Evidence-Based Approaches to Nutritional Modifications to Reduce Atherosclerotic Cardiovascular Disease: An American Society For Preventive Cardiology Clinical Practice Statement. | Am J Prev Cardiol | 2022 | https://conductscience.org/library/papers/35284849 | PubMed |
| 11 | 33961203 | Mendelian randomisation for mediation analysis: current methods and challenges for implementation. | Eur J Epidemiol | 2021 | https://conductscience.org/library/papers/33961203 | PubMed |
| 12 | 34425883 | Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD. | Alzheimers Res Ther | 2021 | https://conductscience.org/library/papers/34425883 | PubMed |
| 13 | 29875488 | Genomic atlas of the human plasma proteome. | Nature | 2018 | https://conductscience.org/library/papers/29875488 | PubMed |
| 14 | 28527048 | Interpreting findings from Mendelian randomization using the MR-Egger method. | Eur J Epidemiol | 2017 | https://conductscience.org/library/papers/28527048 | PubMed |
| 15 | 25939054 | Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. | Annu Rev Genomics Hum Genet | 2015 | https://conductscience.org/library/papers/25939054 | PubMed |
| 16 | 31088786 | Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. | BMJ | 2019 | https://conductscience.org/library/papers/31088786 | PubMed |
| 17 | 34326189 | Relationship between glucosamine use and the risk of lung cancer: data from a nationwide prospective cohort study. | Eur Respir J | 2022 | https://conductscience.org/library/papers/34326189 | PubMed |
| 18 | 36922753 | Comprehensive analysis of metabolic changes in spontaneously hypertensive rats. | Clin Exp Hypertens | 2023 | https://conductscience.org/library/papers/36922753 | PubMed |
| 19 | 21288892 | Structures of human Golgi-resident glutaminyl cyclase and its complexes with inhibitors reveal a large loop movement upon inhibitor binding. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21288892 | PubMed |
| 20 | 37422736 | Association Between Glucosamine Use and the Risk of Incident Heart Failure: The UK Biobank Cohort Study and Mendelian Randomization Analysis. | Mayo Clin Proc | 2023 | https://conductscience.org/library/papers/37422736 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GNPNAT1 | 64841 | PubTator's text mining | https://conductscience.org/library/genes/64841 | NCBI Gene |
| QPCT | 25797 | PubTator's text mining | https://conductscience.org/library/genes/25797 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39596173
GET https://conductscience.org/api/papers/v1/39596173/references?page=2